Legal Representation
Attorney
NANCY A DEL PIZZO
USPTO Deadlines
Next Deadline
174 days remaining
Statement of Use Due - Extension 1 Granted
Due Date
January 07, 2026
Extension Available
Until January 07, 2026
Application History
25 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Jun 25, 2025 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Jun 24, 2025 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
| Jun 24, 2025 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
| Jun 24, 2025 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Jan 7, 2025 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Dec 10, 2024 | TMBN | T | TTAB RELEASE CASE TO TRADEMARKS | Loading... |
| Dec 10, 2024 | OP.T | T | OPPOSITION TERMINATED NO. 999999 | Loading... |
| Dec 10, 2024 | OP.D | T | OPPOSITION DISMISSED NO. 999999 | Loading... |
| Jun 23, 2024 | ETOP | T | EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED | Loading... |
| Jun 21, 2024 | OP.I | T | OPPOSITION INSTITUTED NO. 999999 | Loading... |
| Jan 9, 2024 | ETOF | T | EXTENSION OF TIME TO OPPOSE RECEIVED | Loading... |
| Dec 26, 2023 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Dec 26, 2023 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Dec 6, 2023 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Nov 17, 2023 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Oct 24, 2023 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Oct 24, 2023 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Oct 24, 2023 | ALIE | A | ASSIGNED TO LIE | Loading... |
| May 24, 2023 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Nov 25, 2022 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Nov 25, 2022 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Nov 25, 2022 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Nov 23, 2022 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Nov 4, 2022 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Nov 4, 2022 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
House mark for pharmaceuticals for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders all of the foregoing excluding products related to gene and cell therapies and products primarily indicated for treatment or prevention of vitamin or mineral deficiencies through supplementation
Classification
International Classes
005